Syzygy Therapeutics is categorized under Medical Centers in New York City, NY and active since 2010.
Syzygy Therapeutics was established in 2010, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Medical Centers business, which does work in the B2C market, and is classified as a Medical Centers, under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Averill L Powers at the company’s single location by writing to 405 Lexington Avenue Floor 7, New York City, New York NY 10174 or by phoning (212) 682-6500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Syzygy Therapeutics |
| Contact Person: | Averill L Powers |
| Address: | 405 Lexington Avenue Floor 7, New York City, New York 10174 |
| Phone Number: | (212) 682-6500 |
| Website Address: | syzygytherapeutics.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Centers |
| SIC Code: | 8011 |
| NAICS Code: | 4461100 |
| Share This Business: |
Syzygy Therapeutics was started in 2010 to provide professional Medical Centers under the SIC code 8011 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Averill L Powers for inquiries that concern Syzygy Therapeutics by calling the company number (212) 682-6500, as your correspondence is most welcome. Additionally, the physical location of the single location of Syzygy Therapeutics can be found at the coordinates 40.752182,-73.975427 as well as the street address 405 Lexington Avenue Floor 7 in New York City, New York 10174.
For its online presence, you may visit Syzygy Therapeutics’s website at syzygytherapeutics.com and engage with its social media outlets through on Twitter and on Facebook.